https://www.healio.com/news/psychiatry/20221103/clinical-evaluation-of-opioid-use-disorder-treatment-funded-by-56m-nih-grant
0
0
11/3/22 at 6:02pm
Organization
Healio
Authors
Biopharmaceutical company Aptinyx Inc. announced the finalization of a $5.6 million NIH grant for the development of a novel therapeutic for the treatment of opioid use disorder.According to a release from Aptinyx, the grant will arrive through the Helping to…
Create an account
or login to join the discussion